Pharma Pulse 5/28/24: Keys to Pursuing a Career in Biopharma, Big Tech Moves More AI Spending Abroad & more

MilliporeSigma to Purchase Mirus Bio

With the acquisition, Merck’s US and Canada life science business aims to further increase its viral vector manufacturing capabilities.

Three Keys to Success for Pursuing a Career in the Biopharmaceutical Industry

Building a network, finding your passion, and taking steps to transition into an industry professional can help lead PharmD graduates to success.

Big Tech Moves More AI Spending Abroad

So far this year, Microsoft and Amazon have earmarked more than $40 billion combined for investments in AI-related and data center projects worldwide.

Global Insulin Delivery Systems Strategic Research Report 2024: Market to Reach $16.8 Billion by 2030

The "Insulin Delivery Systems - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Insulin Delivery Systems estimated at US$13.4 Billion in the year 2023, is projected to reach a revised size of US$16.8 Billion by 2030, growing at a CAGR of 3.3% over the analysis period 2023-2030.

ICON plc on LinkedIn:

What’s next for DCTs?

In a recent Pharmaceutical Executive article we share insights on the evolution of this patient centric model and how to maximise the benefits DCTs bring to clinical research with the right processes and tools in place.https://ow.ly/RMM750RJAwg

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs